Furthermore, MSI2 and PRMT5 protein abundance are lower in non-malignant B cells and de novo MCL and DLBCL primary samples compared to relapsed MCL, relapsed DLBCL, and lymphoma cell lines (Fig. 3D). Here, MSI2 is linked to diffuse large B-cell lymphoma.